Abstract

Objective: Knowledge regarding interactions of AFB<sub>1</sub> with the human nervous system and how a naturally occurring level of AFB<sub>1</sub> could potentially induce neuroimmune dysregulation is very limited. To assess the cellular effects of AFB<sub>1</sub> on the human brain, we used the human microglia cell line CHME5 as a model to pinpoint its potential in vivo translation. Methods: We used the CHME5 cell line culture system, multiplex qPCR, (chemi)bioluminescence, Luminex ELISA, and flow cytometry assays to evaluate the toxic effects of a naturally occurring level of AFB<sub>1</sub> on human microglia. Results: A low concentration of AFB<sub>1</sub> upregulates the mRNA expression of many proinflammatory molecules, such as TLRs, MyD88, NFκB, and CxCr4, induces intracellular ATP depletion, and increases caspase-3/7 activity at different time points following exposure to the toxin. Furthermore, AFB<sub>1</sub>-exposed microglia secreted significantly higher levels of IFN-γ and GM-CSF after treatment. We also observed a slight increase in the percentage of apoptotic microglia (annexin V<sup>+</sup>/PI<sup>−</sup>) at 48 h posttreatment. Conclusion: Our work confirmed that the environmentally relevant level of AFB<sub>1</sub> could cause an inflammatory reaction in human microglial cells that is potentially harmful or toxic to the homeostasis of the human central nervous system and might increase susceptibility to neurodegenerative diseases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.